- Investing Ideas
- Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
19
Companies which are more than 50% undervalued based on analyst price target.
19 companies
Green Thumb Industries
Market Cap: CA$2.2b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$10.21
7D
5.9%
1Y
4.2%
Eupraxia Pharmaceuticals
Market Cap: CA$586.6m
A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.
EPRX
CA$9.12
7D
6.7%
1Y
23.2%
Verano Holdings
Market Cap: CA$557.5m
Engages in the cannabis business in the United States.
VRNO
CA$7.72
7D
8.3%
1Y
28.7%
Canopy Growth
Market Cap: CA$544.6m
Engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally.
WEED
CA$1.32
7D
4.8%
1Y
-10.8%
Cresco Labs
Market Cap: CA$408.7m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$0.99
7D
10.0%
1Y
2.1%
Spectral Medical
Market Cap: CA$407.9m
Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.
EDT
CA$1.41
7D
2.9%
1Y
72.0%
TerrAscend
Market Cap: CA$261.1m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TSND
CA$0.77
7D
11.6%
1Y
10.0%
High Tide
Market Cap: CA$261.0m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.17
7D
9.1%
1Y
4.8%
Cardiol Therapeutics
Market Cap: CA$202.9m
A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$1.92
7D
12.9%
1Y
3.8%
Organigram Global
Market Cap: CA$184.4m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$1.37
7D
4.6%
1Y
-27.5%
HLS Therapeutics
Market Cap: CA$131.4m
A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally.
HLS
CA$4.12
7D
-2.1%
1Y
-17.6%
Vext Science
Market Cap: CA$63.2m
Through its subsidiaries, engages in integrated cannabis operations in the United States.
VEXT
CA$0.24
7D
6.5%
1Y
2.1%
Decibel Cannabis
Market Cap: CA$57.7m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.11
7D
0%
1Y
29.4%
Planet 13 Holdings
Market Cap: CA$55.3m
Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.
PLTH
CA$0.17
7D
0%
1Y
-46.8%
Sernova Biotherapeutics
Market Cap: CA$41.5m
Operates as a clinical-stage biotechnology company in Canada.
SVA
CA$0.11
7D
-4.3%
1Y
-42.1%
Optimi Health
Market Cap: CA$38.6m
Operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.
OPTI
CA$6.65
7D
-0.4%
1Y
43.0%
Medicenna Therapeutics
Market Cap: CA$33.2m
A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.
MDNA
CA$0.36
7D
1.4%
1Y
-60.0%
Rubicon Organics
Market Cap: CA$31.8m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.46
7D
-1.1%
1Y
-18.8%
Delivra Health Brands
Market Cap: CA$3.4m
Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.
DHB
CA$0.095
7D
-5.0%
1Y
-53.7%